UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Chemical science (Cambridge), 2023-02, Vol.14 (6), p.1443-1452

2023

Volltextzugriff (PDF)

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

Frontiers in aging neuroscience, 2022-06, Vol.14, p.914017-914017

2022

Volltextzugriff (PDF)

High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders

Cell death & disease, 2022-11, Vol.13 (11), p.999-9, Article 999

2022

Volltextzugriff (PDF)

AI-powered therapeutic target discovery

Trends in pharmacological sciences (Regular ed.), 2023-09, Vol.44 (9), p.561-572

2023

Volltextzugriff (PDF)

Social cognitive role of schizophrenia candidate gene GABRB2

PloS one, 2013-04, Vol.8 (4), p.e62322

2013

Volltextzugriff (PDF)

MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer

Drug discovery today, 2024-11, Vol.29 (11), p.104189, Article 104189

2024

Volltextzugriff (PDF)

Glioma Association and Balancing Selection of ZFPM2

PloS one, 2015-07, Vol.10 (7), p.e0133003-e0133003

2015

Volltextzugriff (PDF)

Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation

Proceedings of the National Academy of Sciences - PNAS, 2023-10, Vol.120 (40), p.e2300215120-e2300215120

2023

Volltextzugriff (PDF)

TNIK’s emerging role in cancer, metabolism, and age-related diseases

Trends in pharmacological sciences (Regular ed.), 2024-06, Vol.45 (6), p.478-489

2024

Volltextzugriff (PDF)

Leveraging AI to identify dual-purpose aging and disease targets

Expert opinion on therapeutic targets, 2024-06, Vol.28 (6), p.473-476

2024

Volltextzugriff (PDF)

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery

Journal of chemical information and modeling, 2024-05, Vol.64 (10), p.3961-3969

2024

Volltextzugriff (PDF)

Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy

International archives of allergy and immunology, 2024-02, Vol.185 (2), p.99-110

2024

Volltextzugriff (PDF)

Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine

Aging (Albany, NY.), 2022-03, Vol.14 (6), p.2475-2506

2022

Volltextzugriff (PDF)

Alternative-splicing in the exon-10 region of GABA(A) receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disorders

PloS one, 2009-09, Vol.4 (9), p.e6977

2009

Volltextzugriff (PDF)

AluScan: a method for genome-wide scanning of sequence and structure variations in the human genome

BMC genomics, 2011-11, Vol.12 (1), p.564-564, Article 564

2011

Volltextzugriff (PDF)

Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response

BMC medical genomics, 2015-07, Vol.8 (1), p.42-42, Article 42

2015

Volltextzugriff (PDF)

Biomedical generative pre-trained based transformer language model for age-related disease target discovery

Aging (Albany, NY.), 2023-09, Vol.15 (18), p.9293-9309

2023

Volltextzugriff (PDF)

GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations

Biochemical Society transactions, 2009-12, Vol.37 (Pt 6), p.1415-1418

2009

Volltextzugriff (PDF)

A recombination hotspot in a schizophrenia-associated region of GABRB2

PloS one, 2010-03, Vol.5 (3), p.e9547-e9547

2010

Volltextzugriff (PDF)

A comprehensive AI‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging

Aging cell, 2023-12, Vol.22 (12), p.e14017-n/a

2023

Volltextzugriff (PDF)

Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery

Aging (Albany, NY.), 2023-06, Vol.15 (11), p.4649-4666

2023

Volltextzugriff (PDF)

Positive Selection within the Schizophrenia-Associated GABAA Receptor β2 Gene

PloS one, 2007-05, Vol.2 (5), p.e462

2007

Volltextzugriff (PDF)

Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform

Aging (Albany, NY.), 2023-04, Vol.15 (8), p.2863-2876

2023

Volltextzugriff (PDF)

Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) gene

PloS one, 2007-05, Vol.2 (5), p.e462-e462

2007

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)
Tagungsberichte
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders

AI-powered therapeutic target discovery

Social cognitive role of schizophrenia candidate gene GABRB2

MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer

Glioma Association and Balancing Selection of ZFPM2

Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation

TNIK’s emerging role in cancer, metabolism, and age-related diseases

Leveraging AI to identify dual-purpose aging and disease targets

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery

Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine

Alternative-splicing in the exon-10 region of GABA(A) receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disorders

AluScan: a method for genome-wide scanning of sequence and structure variations in the human genome

Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response

Biomedical generative pre-trained based transformer language model for age-related disease target discovery

GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations

A recombination hotspot in a schizophrenia-associated region of GABRB2

A comprehensive AI‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging

Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery

Positive Selection within the Schizophrenia-Associated GABAA Receptor β2 Gene

Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform

Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) gene

Suchergebnisse filtern